Glenmark Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 15-Sep-2025.
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Glenmark Pharmaceuticals has fixed September 26, 2025 (2:00 p.m. IST) as the date for its 47th Annual General Meeting, to be held via video conferencing. The record date for the purpose of dividend has been set as September 15, 2025. Shareholders on the register as of that date will receive a dividend of ₹2.50 per equity share for FY ending March 31, 2025, subject to AGM approval. The AGM will also consider the appointment of Walker Chandiok & Co. LLP as new statutory auditors for a five-year term (proposed FY26 audit fee of ₹16 million), ratification of cost auditor remuneration of ₹2.80 million, appointment of Rauthan & Associates as secretarial auditor for five years, and appointment of Ms. Patricia Andrews as a Non-Executive Independent Director for five years from August 14, 2025.
Investors need to hold Glenmark shares by September 15, 2025 to be eligible for the ₹2.50 per share dividend. The change in statutory auditor from Suresh Surana & Associates to Walker Chandiok & Co. LLP marks a notable governance change, while the continuity of dividend payment signals steady shareholder returns.